In this infographic we take a look at the long-acting formulations for HIV prevention and treatment currently in the clinical pipeline – from Phase I to approval.
Browsing: Viral > HIV / AIDS
Results from a new survey of young adults has suggested a poor knowledge of HIV transmission, persisting stigma around living with HIV and high-risk sexual behaviours.
In this article, we explore the crucial role of shared decision-making in HIV treatment and hear from David Hardy (Johns…
Researchers from Gladstone Institutes and their partners at Xyphos Biosciences have demonstrated that a cell-based therapy, convertibleCAR®, appears to reduce the latent HIV reservoir in individuals on antiretroviral therapy.
Research presented at IDWeek has discovered that users of the social networking app, Grindr, took more risks and had more partners but were more likely to use, or be open to using, PrEP compared with those who didn’t use the app.
Researchers have developed an animal model mimicking HIV infection in infants, potentially allowing the development of therapeutics and interventions for the pediatric population.
In a new sequencing study, researchers discovered a transcriptional signature in B cells associated with protection from SIV or HIV infection.
Despite long-term antiretroviral therapy, cerebrospinal HIV reservoirs have been identified in individuals living with the virus and linked with a higher rate of cognitive defects.